FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

5 letters match. Newest first.

  1. Nexus Health Solutions LLC dba Harper Meds

    FDA warned telehealth seller Harper Meds that its website misbrands compounded semaglutide and tirzepatide with false and misleading claims.

    Low
  2. Belle Health LLC dba Belle

    FDA warned Belle Health that its website falsely suggests Belle compounds semaglutide and tirzepatide, making the drugs misbranded.

    Low
  3. Biopreventative Company LLC dba Biopreventative

    FDA told Biopreventative its website claim that compounded tadalafil is "commonly known as Cialis" misbrands the drug.

    Low
  4. HealBerry

    FDA warned HealBerry that claiming compounded semaglutide has the 'same active ingredient as Ozempic and Wegovy' misbrands its drugs.

    Medium
  5. Natural Ophthalmics, Inc.

    FDA warned Natural Ophthalmics that six eye drop products are unapproved new drugs sold without FDA approval.

    High risk